Year |
Citation |
Score |
2020 |
Alper PB, Deane J, Betschart C, Buffet D, Collignon Zipfel G, Gordon P, Hampton J, Hawtin S, Ibanez M, Jiang T, Junt T, Knoepfel T, Liu B, Maginnis J, McKeever U, et al. Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway. Bioorganic & Medicinal Chemistry Letters. 30: 127366. PMID 32738975 DOI: 10.1016/J.Bmcl.2020.127366 |
0.309 |
|
2015 |
Annable T, Tomassian T, Jain S, Leibbrandt M, Cooke MP, Deane JA. Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus. Autoimmunity. 48: 29-39. PMID 25483245 DOI: 10.3109/08916934.2014.959166 |
0.309 |
|
2012 |
Walsh ER, Pisitkun P, Voynova E, Deane JA, Scott BL, Caspi RR, Bolland S. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. 109: 16276-81. PMID 22988104 DOI: 10.1073/pnas.1209372109 |
0.499 |
|
2012 |
Crampton SP, Deane JA, Feigenbaum L, Bolland S. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). 188: 1451-9. PMID 22205024 DOI: 10.4049/Jimmunol.1102705 |
0.347 |
|
2009 |
Oak JS, Chen J, Peralta RQ, Deane JA, Fruman DA. The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cells. Autoimmunity. 42: 447-58. PMID 19811262 DOI: 10.1080/08916930902911746 |
0.739 |
|
2009 |
Oak JS, Deane JA, Kharas MG, Luo J, Lane TE, Cantley LC, Fruman DA. Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase (Proceedings of the National Academy of Sciences of the United States of America (2009) 103, 45, (16882-16887) 10.1073/pnas. 0607984103) Proceedings of the National Academy of Sciences of the United States of America. 106: 10871. DOI: 10.1073/Pnas.0905401106 |
0.702 |
|
2007 |
Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 27: 801-10. PMID 17997333 DOI: 10.1016/J.Immuni.2007.09.009 |
0.328 |
|
2007 |
Matheu MP, Deane JA, Parker I, Fruman DA, Cahalan MD. Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node. Journal of Immunology (Baltimore, Md. : 1950). 179: 2261-9. PMID 17675487 DOI: 10.4049/Jimmunol.179.4.2261 |
0.688 |
|
2007 |
Deane JA, Kharas MG, Oak JS, Stiles LN, Luo J, Moore TI, Ji H, Rommel C, Cantley LC, Lane TE, Fruman DA. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood. 109: 2894-902. PMID 17164340 DOI: 10.1182/Blood-2006-07-038620 |
0.731 |
|
2006 |
Oak JS, Deane JA, Kharas MG, Luo J, Lane TE, Cantley LC, Fruman DA. Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proceedings of the National Academy of Sciences of the United States of America. 103: 16882-7. PMID 17071741 DOI: 10.1073/Pnas.0607984103 |
0.726 |
|
2006 |
Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science (New York, N.Y.). 312: 1669-72. PMID 16709748 DOI: 10.1126/Science.1124978 |
0.394 |
|
2005 |
Brachmann SM, Yballe CM, Innocenti M, Deane JA, Fruman DA, Thomas SM, Cantley LC. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Molecular and Cellular Biology. 25: 2593-606. PMID 15767666 DOI: 10.1128/Mcb.25.7.2593-2606.2005 |
0.599 |
|
2004 |
Deane JA, Trifilo MJ, Yballe CM, Choi S, Lane TE, Fruman DA. Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase. Journal of Immunology (Baltimore, Md. : 1950). 172: 6615-25. PMID 15153476 DOI: 10.4049/Jimmunol.172.11.6615 |
0.735 |
|
2004 |
Deane JA, Fruman DA. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annual Review of Immunology. 22: 563-98. PMID 15032589 DOI: 10.1146/Annurev.Immunol.22.012703.104721 |
0.643 |
|
2004 |
Kharas MG, Deane JA, Wong S, O'Bosky KR, Rosenberg N, Witte ON, Fruman DA. Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells. Blood. 103: 4268-75. PMID 14976048 DOI: 10.1182/Blood-2003-07-2193 |
0.722 |
|
Show low-probability matches. |